Portland, OR -- (SBWIRE) -- 10/05/2017 -- Monoclonal antibodies are replicas of a unique parental cell derived from identical immune cells. These antibodies can bind to a particular antigen when administered, as they have a monovalent affinity. Monoclonal antibodies serve as an important tool to detect or purify substances, owing to their site specificity; thus, they have an important end use in biochemistry, molecular biology, and medicine.
Growth in demand for personalized medicines and surge in development of therapeutic antibodies drives the Monoclonal Antibodies Market. Moreover, advantages such as homogeneity, specificity, and large-scale production; and fewer side effects related to substitute drugs are expected to boost the market growth. However, high cost of R&D activities and expensive treatment options of monoclonal antibodies may restrain this growth.
The global monoclonal antibody market is segmented based on source, production, indication, end user, and region. Based on the source, it is classified into murine, chimeric, humanized, and human. Based on production, it is divided into in vivo and in vitro. Based on indication, it is segmented into cancer, autoimmune diseases, inflammatory diseases, infectious diseases, microbial diseases, and others. The end user includes hospitals, research institutes, and others. Based on region, it is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed across the country level to determine the market size and forecast for each segment and sub-segment.
Exclusive Offer !!! Get Flat 20% discount on this report
Monoclonal Antibody Market Key Segments:
By End User
To request a sample copy of this report, click the link : https://www.alliedmarketresearch.com/request-toc-and-sample/4369
Comprehensive competitive analysis and profiles of major players, such as Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc, Amgen Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., and Daiichi Sankyo Company, Ltd., are provided in this report.